Literature DB >> 25359363

The biomarkers consortium.

David Wholley1.   

Abstract

The Biomarkers Consortium is a public–private biomedical research partnership that seeks to develop and qualify biomarkers across a broad range of diseases in order to accelerate the development of new medicines and improve patient care.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25359363     DOI： 10.1038/nrd4439

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  5 in total

1.  Accelerating identification and regulatory approval of investigational cancer drugs.

Authors:  Laura J Esserman; Janet Woodcock
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

2.  Pathological complete response and accelerated drug approval in early breast cancer.

Authors:  Tatiana M Prowell; Richard Pazdur
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

Review 3.  Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health.

Authors:  George H Talbot; John H Powers; Thomas R Fleming; Judith A Siuciak; John Bradley; Helen Boucher
Journal:  Clin Infect Dis       Date:  2012-06-28       Impact factor: 9.079

4.  Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.

Authors:  Thomas M File; Donald E Low; Paul B Eckburg; George H Talbot; H David Friedland; Jon Lee; Lily Llorens; Ian Critchley; Dirk Thye
Journal:  Clin Infect Dis       Date:  2010-11-10       Impact factor: 9.079

5.  Once-weekly dalbavancin versus daily conventional therapy for skin infection.

Authors:  Helen W Boucher; Mark Wilcox; George H Talbot; Sailaja Puttagunta; Anita F Das; Michael W Dunne
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245
  5 in total
  6 in total

1.  Industry-academia collaborations for biomarkers.

Authors:  Khusru Asadullah; Andreas Busch; Matthias Gottwald; Petra Reinke; Lilla Landeck
Journal:  Nat Rev Drug Discov       Date:  2015-10-30       Impact factor: 84.694

Review 2.  The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?

Authors:  Dorothy M Jones-Davis; Neil Buckholtz
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

3.  Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Authors:  John H Newman; Stuart Rich; Steven H Abman; John H Alexander; John Barnard; Gerald J Beck; Raymond L Benza; Todd M Bull; Stephen Y Chan; Hyung J Chun; Declan Doogan; Jocelyn Dupuis; Serpil C Erzurum; Robert P Frantz; Mark Geraci; Hunter Gillies; Mark Gladwin; Michael P Gray; Anna R Hemnes; Roy S Herbst; Adrian F Hernandez; Nicholas S Hill; Evelyn M Horn; Kendall Hunter; Zhi-Cheng Jing; Roger Johns; Sanjay Kaul; Steven M Kawut; Tim Lahm; Jane A Leopold; Greg D Lewis; Stephen C Mathai; Vallerie V McLaughlin; Evangelos D Michelakis; Steven D Nathan; William Nichols; Grier Page; Marlene Rabinovitch; Jonathan Rich; Franz Rischard; Sharon Rounds; Sanjiv J Shah; Victor F Tapson; Naomi Lowy; Norman Stockbridge; Gail Weinmann; Lei Xiao
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

4.  Hemoglobin state-flux: A finite-state model representation of the hemoglobin signal for evaluation of the resting state and the influence of disease.

Authors:  Randall L Barbour; Harry L Graber; San-Lian S Barbour
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

5.  The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction.

Authors:  Joseph P Menetski; Steven C Hoffmann; Stephanie S Cush; Tania Nayak Kamphaus; Christopher P Austin; Paul L Herrling; John A Wagner
Journal:  Clin Pharmacol Ther       Date:  2019-04       Impact factor: 6.875

Review 6.  Brain Imaging Biomarkers for Chronic Pain.

Authors:  Zhengwu Zhang; Jennifer S Gewandter; Paul Geha
Journal:  Front Neurol       Date:  2022-01-03       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.